Locations
Waltham, MA, USA · Boston, MA, USA
industry
Biotechnology · DeepTech
Size
11-50 employees
Stage
Series A
founded in
2021
SeQure Dx is a pioneering company focused on providing invaluable insights into gene editing therapies, specifically assessing on-target specificity and off-target risks. Their proprietary analytical tools deliver unparalleled sensitivity and scalability, making them a vital partner in the development of safe and effective gene editing solutions. By supporting research and development, informing study design, and enabling clinical trial enrollment, SeQure Dx positions itself as a leader in the gene editing market, addressing critical concerns from physicians and regulators regarding the safety of gene therapies.
Something looks off?On-site & Remote